Drugs / GSK21110183
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00881946 | Jul 2009 → Mar 2012 | hematopoietic and lymphoid cell neoplasm | Accenture | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSK21110183 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00881946 ↗ |